Elisabeth Murphy
Overview
Explore the profile of Elisabeth Murphy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
240
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cibralic S, Hawker P, Khan F, Lucien A, Mendoza Diaz A, Woolfenden S, et al.
Front Child Adolesc Psychiatry
. 2025 Jan;
2():1074004.
PMID: 39816889
Objective: To examine and synthesize the literature on the use of universal developmental screening and surveillance tools in high-income countries in relation to (1) psychometric properties; (2) knowledge, acceptability, and...
2.
Getz K, Smith Z, Botto E, Murphy E, Dauchy A
Ther Innov Regul Sci
. 2024 Mar;
58(3):539-548.
PMID: 38438658
The Tufts Center for the Study of Drug Development (Tufts CSDD) conducted a follow-up study in 2022 to assess trends in protocol amendment experiences and the impact amendments have had...
3.
Walters K, Sajek M, Murphy E, Issaian A, Baldwin A, Harrison E, et al.
RNA
. 2023 Jun;
29(10):1458-1470.
PMID: 37369529
RNA-binding proteins (RBPs) are key regulators of gene expression. Small molecules targeting these RBP-RNA interactions are a rapidly emerging class of therapeutics for treating a variety of diseases. Ro-08-2750 (Ro)...
4.
Mendoza Diaz A, Brooker R, Cibralic S, Murphy E, Woolfenden S, Eapen V
Aust Health Rev
. 2023 Jan;
47(1):72-76.
PMID: 36657451
The purpose of this perspective article is to emphasise the importance of the 'First 2000 Days' policy of life from conception to age five, and to propose new directions in...
5.
Cibralic S, Hawker P, Khan F, Mendoza Diaz A, Woolfenden S, Murphy E, et al.
Int J Environ Res Public Health
. 2022 Dec;
19(23).
PMID: 36497697
Developmental surveillance and screening is recommended for all children under five years of age, especially for those from at-risk populations such as First Nations children. No review to date has,...
6.
French A, Murphy E, Martin F, de Mello N, Rose K
Asia Pac J Ophthalmol (Phila)
. 2022 Sep;
11(5):425-433.
PMID: 36179336
Purpose: The aim was to investigate universality of access, screening rate, and outcomes from the New South Wales (NSW) Statewide Eyesight Preschooler Screening (StEPS) over the period of 2009 to...
7.
Hodgins M, Ostojic K, Hu N, Lawson K, Samir N, Webster A, et al.
BMJ Open
. 2022 Aug;
12(8):e061002.
PMID: 36041760
Introduction: Continuity of child and family healthcare is vital for optimal child health and development for developmentally vulnerable children. Migrant and refugee communities are often at-risk of poor health outcomes,...
8.
Cibralic S, Alam M, Mendoza Diaz A, Woolfenden S, Katz I, Tzioumi D, et al.
BMJ Open
. 2022 Aug;
12(8):e060395.
PMID: 36008078
Objective: To examine and synthesise the literature on adverse childhood experience (ACE) screening in clinical and healthcare settings servicing children (0-11) and young people (12-25). Design: A systematic review of...
9.
Eapen V, Liaw S, Lingam R, Woolfenden S, Jalaludin B, Page A, et al.
BMJ Open
. 2022 Aug;
12(8):e065823.
PMID: 35977775
Introduction: The increasing prevalence of developmental disorders in early childhood poses a significant global health burden. Early detection of developmental problems is vital to ensure timely access to early intervention,...
10.
Kohlhoff J, Dadich A, Varghese J, McKenzie A, Ong N, Pritchard M, et al.
Aust J Gen Pract
. 2022 May;
51(6):439-445.
PMID: 35637591
Background And Objectives: Watch Me Grow - Electronic (WMG-E) platform is an online resource to enhance the capacity of general practitioners (GPs) to involve parents in developmental surveillance. The aim...